Ception's lead drug is reslizumab, a humanized monoclonal antibody against interleukin 5 (IL-5 ... programme investigating orally active anti-tumour necrosis factor receptor agents.

Several medications now calm painful inflammation in the intestines. Diets free of ultraprocessed foods also help ...

Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...

Scientists have found an unlikely anti-aging drug in the form of an anti-inflammatory drug that is designed to inhibit an inflammatory molecule known as interleukin-11 (IL-11). The drug was found ...

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...

In March 2025, Shandong Suncadia Medicine Co., Ltd. conducted a phase II Clinical Study of Efficacy and Safety of HRS-1780 ...

Summary: Tocilizumab is a novel monoclonal antibody that competitively inhibits the binding of interleukin-6 (IL-6 ... or disease-modifying antirheumatic drugs. A large clinical trial is needed ...